ftInvstr

PPLPHARMA · Healthcare ₹245.3 -0.37% Mkt Cap ₹32562 Cr fair

PPLPHARMA

Healthcare Drug Manufacturers - Specialty & Generic

★ Watchlist ⧉ Add to bucket

₹245.3

-0.37% today · 30d +24.42%

as of 2026-11-09

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for PPLPHARMA. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2026-09-30

REVENUE

₹2617 Cr

+28.05% YoY

NET PROFIT

₹5 Cr

OPM

14.5%

+3.87pp YoY

EPS

₹0.04

Intrinsic value · DCF ₹237.10 · Margin of safety -3.3% (fair) · FCF yield 2.34%

◇ Sector Position

PEERPEROCE %

PPLPHARMA—3.0

SUNPHARMA37.7921.44

DIVISLAB93.121.56

ZYDUSLIFE28.424.22

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance STRONG 90

Valuation — —

Growth MUTED 35

Profitability AVERAGE 42

Technicals NEUTRAL 60

Risk LOW 80

Key Stats

P/B

4.2

52W HIGH

₹250.4

OFF HIGH

-2.04%

DIV YIELD

0.0%

MKT CAP

₹32562 Cr

◉ Active Signals

MACDBullish3.6027

RSI(14)Bearish72.52

Near 52W HighBullish-2.04

Street Consensus

11 analysts

₹262.91

mean target

Low ₹220.0Now ₹245.3High ₹300.0

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold PPLPHARMA and at what entry.